Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | yin | crystal structure of MDM2 with chromenotriazolopyrimidine 1 | 3jzk | 71.93 | | 1230. |
2 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | y30 | Structure of a novel submicromolar MDM2 inhibitor | 4mdn | 76.05 | | 600. |
3 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | mi6 | Structure of human MDM2 protein in complex with Mi-63-analog | 3lbl | 75.46 | | 36. |
4 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | hu8 | HDM2 (17-111, WILDTYPE) COMPLEXED WITH COMPOUND 10 AT 1.21A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes | 6q9o | 83.19 | | no data |
5 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | h28 | Crystal structure of MDM2 in complex with compound 13. | 6i3s | 80.65 | | no data |
6 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | diz | Structure of Human MDM2 in complex with a Benzodiazepine Inhibitor | 1t4e | 77.55 | | 80. |
7 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 9qw | HDM2 (17-111, WILD TYPE) COMPLEXED WITH NVP-HDM201 AT 1.56A | 5oc8 | 75.32 | | no data |
8 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 7hc | MDM2 in complex with SAR405838 | 5trf | 78.4 | | 0.88 |
9 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 6zt | Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument | 5ln2 | 65.47 | | no data |
10 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 6ss | Discovery of New Natural-product-inspired Spiro-oxindole Compounds as Orally Active Inhibitors of the MDM2-p53 Interaction: HDM2 (MDM2) IN COMPLEX WITH COMPOUND 6g | 5lay | 82.05 | | 34. |
11 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 4th | Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with cpd2 | 4zyi | 75.24 | | 8. |
12 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 35s | co-crystal structure of MDM2 (17-111) with compound 16, {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-(6-CYCLOPROPYLPYRIDIN-2-YL)PROPYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID | 4qo4 | 75.47 | | 5. |
13 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 2u7 | Co-Crystal Structure of MDM2 with Inhibitor Compound 49 | 4ogv | 69.82 | | 9. |
14 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 2tz | co-crystal structure of MDM2(17-111) in complex with compound 48 | 4occ | 86 | | 2. |
15 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 2tw | Co-crystal structure of MDM2 with Inhibitor Compound 4 | 4oba | 78.8 | | 0.4 |
16 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 2sw | co-crystal structure of MDM2 (17-111) in complex with compound 25 | 4oas | 83.93 | | 0.1 |
17 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 1mt | Co-crystal structure of MDM2 with inhibitor (2'S,3R,4'S,5'R)-N-(2-aminoethyl)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide | 4jvr | 72.59 | | no data |
18 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 1mq | Co-crystal structure of MDM2 with inhibitor (2R,3E)-2-[(2S,3R,6S)-2,3-bis(4-chlorophenyl)-6-(4-fluorobenzyl)-5-oxomorpholin-4-yl]pent-3-enoic acid | 4jve | 72.48 | | 86. |
19 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 1mo | Co-crystal structure of MDM2 with inhibitor (2S,5R,6S)-2-benzyl-5,6-bis(4-chlorophenyl)-4-methylmorpholin-3-one | 4jv9 | 67.3 | | 1800. |
20 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 1mn | Co-crystal structure of MDM2 with inhibitor (2S,5R,6S)-2-benzyl-5,6-bis(4-bromophenyl)-4-methylmorpholin-3-one | 4jv7 | 67.31 | | 1000. |
21 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 0r2 | crystal structure of MDM2 (17-111) in complex with compound 23 | 4ere | 73.5 | | 4.2 |
22 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | tj2 | Structure of a novel submicromolar MDM2 inhibitor | 3tj2 | 72.91 | | no data |
23 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 0y7 | Ordering of the N Terminus of Human MDM2 by Small Molecule Inhibitors | 4hbm | 91.84 | | 12. |
24 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 1my | Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid | 4jwr | 74.3 | | 610. |
25 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | Q00987 | | 6sk | Novel Spiro[3H-indole-3,2 -pyrrolidin]-2(1H)-one Inhibitors of the MDM2-p53 Interaction: HDM2 (MDM2) in complex with compound 6b | 5lav | 76.09 | | 819. |